SPEAKER INDEX CONTENTS INSERTS
APPENDIX 4
CLARK 21 22 25 29 31 32 33 34 35
113
DOCUMENTS SUBMITTED FOR THE RECORD 5
FINE 63 64 65 66 67 68 69 70 71
72 73 74 75
GOZANI 75 76 78 79 80 81 82 83 84
85 86 88 89 90 113
HEARING 4
HOLLIS 105 106 107 108 109 110 111 112
HUNTER 6 10 11 13 14 15 19 20 22
25 28 33 35 39 40 41 42 43
44 47 52 53 54 55 56 58 59
62 63 64 65 66 67 68 69 73
75 76 78 79 80 81 82 83 84
85 87 88 91 92 93 94 95 97
98 99 100 101 102 103 104 105 106
107 108 109 110 111 112 113 114
LANGEVIN 33 42 43 48 58 59 61 62 72
73
LARSON 29 31 33
MEEHAN 8 17 18 19 56 69 70 71 72
99 100 101 114
MOLDT 35 39 40 41 42 43 44 45 46
47 114
MOTTUR 48 52 53 54 56 58 59 61 62
MULLIGAN 11 14 15 16 17 18 19 20 113
PREPARED STATEMENTS 5
QUESTIONS AND ANSWERS SUBMITTED FOR THE RECORD 5
RAUSCH 91 92 94 95 97 98 99 100 101
102 103 104
REYES 18 46 47 53 54 55 56 81 84
85 86 87 88
SANCHEZ 40 44 45
SAXTON 73 74 75 88 90
THOMPSON 15
CONTENTS SPEAKERS INSERTS
OPENING STATEMENT OF HON. DUNCAN HUNTER, A REPRESENTATIVE FROM CALIFORNIA, CHAIRMAN, MILITARY
RESEARCH AND DEVELOPMENT SUBCOMMITTEE
PAGE 6
STATEMENT OF ANTHONY MULLIGAN, PRESIDENT, ADVANCED CERAMICS RESEARCH
PAGE 11
STATEMENT OF LAWRENCE CLARK, CHAIRMAN OF THE BOARD, SONALYSTS
PAGE 21
STATEMENT OF VERA MOLDT, VICE PRESIDENT CORPORATE DEVELOPMENT, AMBIENT CONTROL SYSTEM
PAGE 35
STATEMENT OF PETER MOTTUR, CEO, LIVEWAVE
PAGE 48
STATEMENT OF DAVID FINE, CEO CYTERRA CORPORATION
PAGE 63
STATEMENT OF TSAHI GOZANI, PRESIDENT AND CEO, ANCORE
PAGE 76
STATEMENT OF CARL RAUSCH, CHAIRMAN AND CEO, BIOPURE
PAGE 91
STATEMENT OF RICHARD HOLLIS, PRESIDENT AND CEO, HOLLIS EDEN PHARMACEUTICALS
PAGE 105
INSERTS SPEAKERS CONTENTS
NO INSERTS IN THIS HEARING